View of MOLECULAR DOCKING ON BIOACTIVE COMPOUNDS OF GENISTEIN QUERCETIN AND RESVERATROL TO BRCA1, ERA, AND EGFR RECEPTORS IN BREAST CANCER

Return to Article Details MOLECULAR DOCKING ON BIOACTIVE COMPOUNDS OF GENISTEIN QUERCETIN AND RESVERATROL TO BRCA1, ERA, AND EGFR RECEPTORS IN BREAST CANCER Download Download PDF